BIOGEN INC (BIIB) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:BIIB • US09062X1037

186.1 USD
+0.65 (+0.35%)
Last: Feb 5, 2026, 10:45 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BIIB revenue by date.BIIB revenue by date.
10.173B
-7.37%
9.836B
-3.32%
9.676B
-1.62%
10.025B
3.61%
9.515B
-5.09%
9.481B
-0.36%
9.561B
0.84%
9.525B
-0.38%
9.429B
-1.01%
9.356B
-0.77%
9.414B
0.62%
9.402B
-0.13%
EBITDA
YoY % growth
BIIB ebitda by date.BIIB ebitda by date.
3.742B
-6.03%
2.669B
-28.68%
3.325B
24.56%
3.185B
-4.20%
3.186B
0.03%
3.136B
-1.57%
3.275B
4.43%
3.316B
1.25%
3.066B
-7.54%
3.853B
25.67%
4.248B
10.25%
4.69B
10.40%
EBIT
YoY % growth
BIIB ebit by date.BIIB ebit by date.
3.224B
-7.75%
2.174B
-32.56%
2.651B
21.94%
2.858B
7.79%
2.819B
-1.36%
2.914B
3.37%
3.111B
6.76%
3.102B
-0.29%
3.09B
-0.39%
3.159B
2.23%
3.29B
4.15%
3.118B
-5.23%
Operating Margin
BIIB operating margin by date.BIIB operating margin by date.
31.69%22.11%27.40%28.51%29.63%30.74%32.54%32.57%32.77%33.76%34.95%33.16%
EPS
YoY % growth
BIIB eps by date.BIIB eps by date.
18.45
-3.81%
15.08
-18.27%
16.47
9.22%
15.26
-7.36%
15.45
1.24%
16.22
4.98%
16.74
3.23%
16.96
1.31%
16.54
-2.48%
17.18
3.85%
17.92
4.35%
17.49
-2.42%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.63
-52.49%
3.61
19.37%
4.04
-26.22%
3.83
-20.47%
3.41
108.69%
4.14
14.87%
4.40
8.94%
4.60
20.26%
4.62
35.47%
Revenue
Q2Q % growth
2.246B
-8.50%
2.317B
-4.69%
2.434B
-7.99%
2.428B
-4.21%
2.401B
6.90%
2.315B
-0.09%
2.413B
-0.86%
2.434B
0.25%
2.446B
1.87%
EBITDA
Q2Q % growth
389.67M
-68.65%
697.35M
-19.12%
788.46M
-39.46%
792.43M
-37.80%
915.25M
134.88%
N/AN/AN/AN/A
EBIT
Q2Q % growth
346.8M
-39.17%
639.93M
-5.75%
729.57M
-21.12%
719.5M
3.61%
679.74M
96.00%
712.98M
11.42%
729.3M
-0.04%
737.46M
2.50%
716.04M
5.34%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
4.81
17.89%
3.960.8521.48%
Q2 2025
Q2Q % growth
5.47
3.60%
3.941.5338.92%
Q1 2025
Q2Q % growth
3.02
-17.71%
2.580.4417.28%
Q4 2024
Q2Q % growth
3.44
4.24%
3.420.020.67%
Q3 2024
Q2Q % growth
4.08
-6.42%
3.870.215.50%
Q2 2024
Q2Q % growth
5.28
31.34%
4.111.1728.61%
Q1 2024
Q2Q % growth
3.67
7.94%
3.520.154.32%
Q4 2023
Q2Q % growth
3.30
-18.52%
3.250.051.62%
Q3 2023
Q2Q % growth
4.36
-8.60%
4.050.317.59%
Q2 2023
Q2Q % growth
4.02
-23.43%
3.840.184.66%
Q1 2023
Q2Q % growth
3.40
-22.37%
3.340.061.66%
Q4 2022
Q2Q % growth
4.05
19.47%
3.550.5013.99%
Q3 2022
Q2Q % growth
4.77 4.220.5513.06%
Q2 2022
Q2Q % growth
5.25
-7.57%
4.141.1126.66%
Q1 2022
Q2Q % growth
4.38
-17.98%
4.47-0.09-1.93%
Q4 2021
Q2Q % growth
3.39
-25.98%
3.45-0.06-1.66%
Q3 2021
Q2Q % growth
4.77
-46.04%
4.170.6014.44%
Q2 2021
Q2Q % growth
5.68
-44.64%
4.631.0522.64%
Q1 2021
Q2Q % growth
5.34
-41.58%
5.140.203.81%
Q4 2020
Q2Q % growth
4.58 4.97-0.39-7.80%
Q3 2020
Q2Q % growth
8.84 8.200.647.80%
Q2 2020
Q2Q % growth
10.26 8.192.0725.23%
Q1 2020
Q2Q % growth
9.14 7.891.2515.88%
BIIB Yearly EPS VS EstimatesBIIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
2.535B
2.79%
2.386B148.7M6.23%
Q2 2025
Q2Q % growth
2.646B
7.33%
2.37B275.5M11.62%
Q1 2025
Q2Q % growth
2.431B
6.13%
2.279B152M6.67%
Q4 2024
Q2Q % growth
2.455B
2.87%
2.452B2.7M0.11%
Q3 2024
Q2Q % growth
2.466B
-2.54%
2.483B-17M-0.68%
Q2 2024
Q2Q % growth
2.465B
0.36%
2.429B35.9M1.48%
Q1 2024
Q2Q % growth
2.291B
-7.00%
2.358B-67.5M-2.86%
Q4 2023
Q2Q % growth
2.386B
-6.20%
2.514B-127.7M-5.08%
Q3 2023
Q2Q % growth
2.53B
0.87%
2.446B84.3M3.45%
Q2 2023
Q2Q % growth
2.456B
-5.14%
2.412B44M1.82%
Q1 2023
Q2Q % growth
2.463B
-2.72%
2.389B74M3.10%
Q4 2022
Q2Q % growth
2.544B
-6.94%
2.491B53M2.13%
Q3 2022
Q2Q % growth
2.509B
-9.73%
2.518B-9.5M-0.38%
Q2 2022
Q2Q % growth
2.589B
-6.70%
2.522B67.1M2.66%
Q1 2022
Q2Q % growth
2.532B
-6.02%
2.551B-19.2M-0.75%
Q4 2021
Q2Q % growth
2.734B
-4.16%
2.669B64.8M2.43%
Q3 2021
Q2Q % growth
2.779B
-17.69%
2.724B54.9M2.02%
Q2 2021
Q2Q % growth
2.775B
-24.63%
2.657B118M4.44%
Q1 2021
Q2Q % growth
2.694B
-23.78%
2.707B-13M-0.48%
Q4 2020
Q2Q % growth
2.853B 2.856B-3.4M-0.12%
Q3 2020
Q2Q % growth
3.376B 3.406B-29.9M-0.88%
Q2 2020
Q2Q % growth
3.682B 3.497B184.6M5.28%
Q1 2020
Q2Q % growth
3.534B 3.475B59.3M1.71%
BIIB Yearly Revenue VS EstimatesBIIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.53% -52.97% 0.19% -5.23%
Revenue-0.13% -2.6% 0.03% 1.55%